Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects. - Wikidata - awgldk - TriplyDB

Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects.

Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects.

http://www.wikidata.org/entity/Q34182705

about

The role of adipokines in chronic inflammation Metabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and Hepatokines Obesity, inflammation, and lung injury (OILI): the good.WNT5A-JNK regulation of vascular insulin resistance in human obesity.Curcumin and obesity.Wnt signaling and the control of human stem cell fate.Selective modulation of Wnt ligands and their receptors in adipose tissue by chronic hyperadiponectinemia.B Lymphocyte Stimulator (BLyS) is expressed in human adipocytes in vivo and is related to obesity but not to insulin resistance.Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition.Lighting the fat furnace without SFRP5 Adipose tissue Mest and Sfrp5 are concomitant with variations of adiposity among inbred mouse strains fed a non-obesogenic diet Secreted Frizzled-related Protein 5 Diminishes Cardiac Inflammation and Protects the Heart from Ischemia/Reperfusion Injury.Molecular correlates of fat mass expansion in C57BL/6J mice after short-term exposure to dietary fat.Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.Medicinal chemistry of the epigenetic diet and caloric restriction.Effect of Sfrp5 on cytokine release and insulin action in primary human adipocytes and skeletal muscle cells.Hypoxia in Obesity and Diabetes: Potential Therapeutic Effects of Hyperoxia and Nitrate.Bone marrow sFRP5 level is negatively associated with bone formation markers.Downregulation of Sfrp5 promotes beta cell proliferation during obesity in the rat.The wingless-related integration site-5a/secreted frizzled-related protein-5 system is dysregulated in human sepsis.Glypican-4 is a new comer of adipokines working as insulin sensitizer.Inverse associations between serum levels of secreted frizzled-related protein-5 (SFRP5) and multiple cardiometabolic risk factors: KORA F4 study.Plasma Sfrp5 levels correlate with determinants of the metabolic syndrome in Chinese adults.Declined plasma sfrp5 concentration in patients with type 2 diabetes and latent autoimmune diabetes in adults.Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression.Balanced duo of anti-inflammatory SFRP5 and proinflammatory WNT5A in children.A novel role for the Wnt inhibitor APCDD1 in adipocyte differentiation: Implications for diet-induced obesity.Common genetic variation in sFRP5 is associated with fat distribution in men.SFRP5 correlates with obesity and metabolic syndrome and increases after weight loss in children.Longitudinal Increases in Adiposity Contribute to Worsening Adipokine Profile over Time in Mexican Americans.Reduced skeletal muscle secreted frizzled-related protein 3 is associated with inflammation and insulin resistance.Association of asymptomatic target organ damage with secreted frizzled related protein 5 in the elderly: the Northern Shanghai Study.Sfrp5 correlates with insulin resistance and oxidative stress.Cloning and Expression of SFRP5 in Tibetan Chicken and its Relationship with IMF Deposition.Nucleotide variation of sFRP5 gene is not associated with obesity in children and adolescents.Secreted frizzled-related protein 5 suppresses inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes through down-regulation of c-Jun N-terminal kinase.The Wnt antagonist and secreted frizzled-related protein 5: implications on lipid metabolism, inflammation and type 2 diabetes mellitus.Adipose tissue-derived cytokines and their correlations with clinical characteristics in Vietnamese patients with type 2 diabetes mellitus.Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls

P2860

Q26852901-6DC1759B-464B-4B3A-9901-C0F67D6AE18F Q28066564-880CD9B5-06E0-4A0B-8141-7DD482940455 Q30363313-77BA6684-AF1C-4CF5-A222-009D1A43EF69 Q33853951-9A836DE0-F745-4F26-BDDE-AF3F77BC109A Q34647452-55CA3105-DD93-42AA-861B-3274153DEE69 Q34658275-7EC4D9A9-72F4-4BEA-9CB8-C3CCE3F6FFD3 Q34825893-2EAF93A7-CDD5-4319-A4EC-2F3F0BE765EB Q35146857-29686BFD-0807-4ED0-A0D1-06919A88C285 Q35878960-252082FD-15FD-462A-8CBB-06219E8F83EE Q36068357-784456EE-2ADB-4B47-B6E4-2E943219E5C4 Q36068371-0D0364B1-7441-4CE2-B7AC-9D2A8150531D Q36304460-7BDE1909-F0DD-48DE-BD43-789233F64CFC Q36548318-204C7A24-07DB-476C-AA17-BD00B42524B2 Q36711883-A147AC15-38AC-40DA-AFC2-8785B6DA3DF1 Q36951691-E8FC557F-8E18-41CA-86EE-D7E7B29C9EC3 Q37416325-8B2B13E5-9BDF-4424-98DC-6EB4BD5B4A4C Q37499849-45886A8F-E89A-4404-8D20-3D752594EE8B Q38728642-EC35ED57-856C-439C-B0CB-B64A9D8BBCC0 Q39093353-64A856DD-3B9A-4E19-AED1-3448CB221594 Q39100118-0BD9606C-7B57-47D0-90A8-60CFD5FACC68 Q39100759-D2D26310-F749-4612-AEDC-7B21447F9C49 Q39428326-3C37FA3C-EE27-44B0-80DE-D75D82895CB5 Q40066352-5F46C0D9-8C38-4992-A439-416775DB114B Q40290462-95641621-3CE7-48FF-AE8D-A0B04F75768D Q41603899-D663ABE1-C61B-44A6-8558-43F6C23B7053 Q41849677-06FC32EE-6B02-49F8-98FC-5811AAE722E6 Q42233299-3F8F03F8-909C-4A16-A6F1-852517769154 Q42802504-26564AD3-D2ED-43FB-B251-FD73821244E8 Q44444836-33EDA99A-17D7-47FE-BBA8-3B741C4A73CA Q47194990-9FD35B55-2E6B-4554-8A5C-68A8FBF26F9C Q50050118-48ED2168-46A5-4AD6-BC55-265AD9B44124 Q50870803-5261B39D-AF49-4581-903E-6BB05803A21C Q51245014-F2BE7325-CC1A-441B-86F4-CD50830473CA Q51260857-FAA48311-0BEA-420D-A8B6-90FE4DCF8DF8 Q51548151-D2D73724-BE6F-4A36-8F6A-FAAC2A7D789E Q51589491-220E2CFB-7127-40D7-9DB3-36B162175A2B Q53055634-44A2BDE5-68CA-45CF-AC18-D8257A941AA4 Q54107821-91BD304E-6809-4A6D-8B0F-F8BE3B916C44 Q55445346-8C715AFE-CA2D-4FB4-A6FA-5D99A42409FF Q58828952-B323BAEA-B921-4DFF-A76E-B9336E77D5F6

P2860

Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects.

http://www.wikidata.org/entity/Q34182705

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Pro-inflammatory wnt5a and ant ...... ctors in obese human subjects.

@ast

Pro-inflammatory wnt5a and ant ...... ctors in obese human subjects.

@en

Pro-inflammatory wnt5a and ant ...... ctors in obese human subjects.

@nl

type

label

Pro-inflammatory wnt5a and ant ...... ctors in obese human subjects.

@ast

Pro-inflammatory wnt5a and ant ...... ctors in obese human subjects.

@en

Pro-inflammatory wnt5a and ant ...... ctors in obese human subjects.

@nl

prefLabel

Pro-inflammatory wnt5a and ant ...... ctors in obese human subjects.

@ast

Pro-inflammatory wnt5a and ant ...... ctors in obese human subjects.

@en

Pro-inflammatory wnt5a and ant ...... ctors in obese human subjects.

@nl

P1433

Q34182705-A6603E2F-51D2-4AE5-9D1E-3148584FD254

P1476

Q34182705-186CFFE7-2011-4629-8C94-6E34A21733FE

P2093

Q34182705-1A339D0E-14EF-4C4B-AC28-DC2467FDCBEC

Q34182705-481DF94D-3226-415D-91A7-A887B958D603

Q34182705-6697C77B-FDD0-4F86-9809-094A9BCB3223

Q34182705-76A216B8-6D49-4556-BF22-320A572C162D

Q34182705-8818D8A3-85C0-4982-8E09-D0A7C6EF28CB

Q34182705-96A31D20-6315-4B83-8310-FF2B0689CBB8

Q34182705-C6A7770D-2ABC-49EC-91BE-9401D2697D7B

Q34182705-E3203338-0631-495A-B546-2EBF625A545D

Q34182705-EFBDB187-879E-4DC1-9E9C-CDC241420280

P2860

Q34182705-08A77D85-5AC4-4779-9857-6976740327FE

Q34182705-097E0450-12BE-46E2-A9F2-8908C3C356F6

Q34182705-39241E2C-C2EC-4945-87D3-BCA54AE04225

Q34182705-4DF1A317-4E2E-4F17-83AF-89476961323C

Q34182705-52980912-62F6-4A48-BCA1-D75DFA88D575

Q34182705-567773EE-55D1-4FD3-BA5B-5730624B1463

Q34182705-599D5C46-EA66-4879-97B6-9AFFC6216B44

Q34182705-5C7A71FF-7DD5-464D-B2BB-3F04D944758E

Q34182705-5DEFE384-558A-4EC6-8C7E-27EE816F2BB4

Q34182705-70E9639A-4E9B-4254-9FE7-AEEA57C17D2C

P304

Q34182705-043CB2DA-26F1-4D76-BC82-C35A83683E2A

P31

Q34182705-4E906AFC-1B9C-47DA-8AC1-315FEAD8CB18

P356

Q34182705-A2867FD4-7E45-4221-9114-6F532E5B2BF9

P407

Q34182705-FEBEEE7B-FF9A-4F5F-908E-00E09551094B

P433

Q34182705-6000D100-D4EE-4AF2-AC79-A4E36AEF4EAE

P478

Q34182705-9A4A1781-3E00-4318-865C-65CB4E00582D

P577

Q34182705-17316FE8-CA54-40E6-A1F6-C5FB159C6102

P5875

Q34182705-68ADC018-A539-4386-A437-5D0F2F757E56

P698

Q34182705-80057E36-FA38-49D9-86FC-4202BAB7AC1D

P921

Q34182705-00AE7983-12CD-4DE8-9A0B-F3A039934B32

Q34182705-065F72BA-2832-4A81-8DF8-A09E26AB260C

Q34182705-65A99809-9A26-4198-9FBC-0C64542F6AA5

P932

Q34182705-E19AE36B-A9DE-42EE-99F2-FC80678C9A87

P356

JOURNAL.PONE.0032437

P1433

P1476

Pro-inflammatory wnt5a and ant ...... ctors in obese human subjects.

@en

P2093

Burkhard Brandt

http://www.w3.org/2001/XMLSchema#string

Dominik M Schulte

http://www.w3.org/2001/XMLSchema#string

Frank Oberhäuser

http://www.w3.org/2001/XMLSchema#string

Heike Güdelhöfer

http://www.w3.org/2001/XMLSchema#string

Katrin Neumann

http://www.w3.org/2001/XMLSchema#string

Matthias Laudes

http://www.w3.org/2001/XMLSchema#string

Michael Faust

http://www.w3.org/2001/XMLSchema#string

Nike Müller

http://www.w3.org/2001/XMLSchema#string

Wilhelm Krone

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of adipogenesis by Wnt signaling

Role of WNT-5a in the determination of human mesenchymal stem cells into preadipocytes

Chibby, a nuclear beta-catenin-associated antagonist of the Wnt/Wingless pathway

Dapper 1 antagonizes Wnt signaling by promoting dishevelled degradation

Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10

Dact1, a nutritionally regulated preadipocyte gene, controls adipogenesis by coordinating the Wnt/beta-catenin signaling network

Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

Wnt signaling inhibits adipogenesis through beta-catenin-dependent and -independent mechanisms.

WNT10B mutations in human obesity.

P304

e32437

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0032437

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221882849

http://www.w3.org/2001/XMLSchema#string

P698

22384249

http://www.w3.org/2001/XMLSchema#string

P921

human subject research

P932

3285685

http://www.w3.org/2001/XMLSchema#string